Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several

Next month, the Department of Health and Human Services is slated to finalize the first major update to HIPAA in more than a decade, which will force hospitals to adopt

Chiesi Group built its rare disease portfolio through business deals and the company has its biggest one yet with a $1.9 billion agreement to buy KalVista Pharmaceuticals, a biotech whose

A bipartisan group of lawmakers recently introduced companion versions of the Medicare Advantage Improvement Act of 2026 in both the House and Senate, aiming to strengthen oversight of Medicare Advantage. 

Medical device giant Medtronic confirmed over the weekend that its systems had been hacked by an unauthorized party. Here are six things to know about the cyberattack. —Medtronic said that

Biopharmaceutical companies continue to hunt for new immunology drugs that bring patients the same benefit as injectable antibody medicines, but in the form of more convenient daily pills. Coultreon Biopharma

Issues with deployment and scaling are the real barriers holding back healthcare AI from delivering value, according to leaders at AI companies Nvidia and Hoppr. That’s why they’re shifting their

It’s a journalist’s dream to interview articulate, sincere, no-holds-barred CEOs. When they actually create headlines, it’s like manna from heaven. And that’s precisely what happened last week at the annual

Artificial intelligence is rapidly becoming embedded across healthcare, from clinical documentation to diagnostic support. But as organizations move beyond pilot programs, a structural challenge is emerging: AI is only as

As AI chatbots become more popular in mental healthcare, the American Medical Association is urging Congress to strengthen safeguards. The organization sent letters to the Congressional Artificial Intelligence Caucus, the